Nachrichten zur Jazz Pharmaceuticals PLC Aktie

Jazz Pharma investor event October 26 on Xywav launch

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Webcast for Xywav Investor Update

DUBLIN , Oct. 19, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a…

New Data for Zepzelca™ (lurbinectedin) to be Presented at IASLC 2020 North America Conference on Lung Cancer

DUBLIN , Oct. 14, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its partner PharmaMar (MSE:…

Jazz Pharmaceuticals: Long-Term Prospects Jazz Up A Modest Upside

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia

DUBLIN , Oct. 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Is Jazz Pharmaceuticals a Top Stock to Buy Now?

Despite a poor performance of late, this biotech stock could bounce back....…

Jazz Pharmaceuticals Launches Initiative to Help Educate People Living with Rare Form of Leukemia

DUBLIN , Sept. 17, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Proactive news headlines: Redx Pharma, Amryt Pharma, Blue Star Capital, Argo Blockchain, Bango …

Redx Pharma PLC (LON:REDX) has unveiled a collaboration with a US company called Jazz Pharmaceuticals to discover and develop two…

Redx Pharma inks research pact with Jazz Pharma for cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies

DUBLIN , Sept. 9, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Redx Pharma unveils second major collaboration in a month as it strengthens ties with Jazz Pharmaceuticals

Redx Pharma PLC (LON:REDX) has unveiled a collaboration with a US company called Jazz Pharmaceuticals to discover and develop two…

Redx Pharma inks research collaboration agreement with Jazz Pharmaceuticals

Cancer and fibrosis focused Redx Pharma said it had signed a new research collaboration agreement with Jazz Pharmaceuticals to discover…

Jazz Pharmaceuticals Announces Participation at Three Upcoming Virtual Investor Conferences

DUBLIN , Sept. 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Jazz Pharmaceuticals to Present New Data on Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Sunosi® (solriamfetol) at Virtual SLEEP 2020

DUBLIN , Aug. 27, 2020 /PRNewswire/ -- Jazz Pharmaceuticals…

Jazz Pharma adds to Q2 beat/guidance raise-stoked rally

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharma (JAZZ) Beats on Q2 Earnings & Sales, Raises View

Jazz Pharmaceuticals (JAZZ) reports better-than-expected second-quarter 2020 earnings and revenues. It raises its guidance for 2020. Shares rise....…

Jazz Pharmaceuticals plc 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals (JAZZ) Q2 Earnings and Revenues Beat Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of 9.76% and 11.06%, respectively, for the quarter ended June 2020. Do the…

Jazz Pharmaceuticals plc: 10-Q Report

10-Q...…

Jazz Pharmaceuticals plc: 8-K Report

8-K...…

Jazz Pharmaceuticals gets US FDA approval of Xywav for cataplexy associated with narcolepsy

Xywav is an oxybate product with a unique composition of cations resulting in 92 percent less sodium – or approximately…

Jazz Pharmaceuticals Wins FDA Approval for Its New Narcolepsy Drug

Xywav has been shown to reduce both cataplexy and excessive daytime sleepiness in narcolepsy patients....…

Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy

DUBLIN , July 22, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Jazz Pharmaceuticals to Report 2020 Second Quarter Financial Results on August 4, 2020

DUBLIN , July 21, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced…

Jazz Pharmaceuticals: Buy, Sell, Or Hold

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals: Undervalued Mid-Sized Pharma Has Assets To Make Up For Falling Xyrem Sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Jazz Pharmaceuticals Is A Hot Buy Right Now

A new small-cell lung cancer drug approval isnt the only thing the company has going for it....…

Jazz Pharmaceuticals plc: 8-K Report

8-K...…

BofA Raises Jazz Pharma Estimates After Zepzelca Update

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) provided encouraging updates on its commercial efforts in a recent conference call on the lung…

Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca™ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer

DUBLIN , June 15, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced along…

Jazz Pharma prices $850M exchangeable debt offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 2.000% Exchangeable Senior Notes due 2026

DUBLIN , June 9, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals")…

Jazz Pharma initiates $850M debt offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2026

DUBLIN , June 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Jazz Pharmaceuticals: Pandemic Leaves The Leading Drug In A Catch 22

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences

DUBLIN , May 27, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Jazz Pharmaceuticals (JAZZ) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings

DUBLIN , May 14, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…

Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States

WILLINGTON , England and DUBLIN , May 11,…